Vincenzo Colangeli Selected Research

Vincenzo Colangeli Research Topics

Disease

10	HIV Infections (HIV Infection) 02/2021 - 12/2006
5	Weight Gain 04/2024 - 04/2020
5	Inflammation (Inflammations) 02/2021 - 05/2012
5	Disease Progression 03/2015 - 01/2006
4	Hypertension (High Blood Pressure) 11/2019 - 08/2011
4	Coinfection 01/2019 - 03/2007
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 02/2011
4	Proteinuria 01/2018 - 02/2014
3	Atherosclerosis 02/2021 - 03/2013
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2021 - 01/2017
3	Viremia 10/2017 - 01/2006
3	Hypercholesterolemia 01/2014 - 05/2012
2	Insulin Resistance 04/2024 - 01/2019
2	Body Weight (Weight, Body) 04/2024 - 07/2023
2	Carotid Artery Diseases 01/2020 - 03/2013
2	Chronic Renal Insufficiency 11/2019 - 01/2018
2	Diabetes Mellitus 11/2019 - 01/2019
2	Neoplasms (Cancer) 07/2019 - 12/2014
2	Vitamin D Deficiency 07/2019 - 01/2017
2	Infections 01/2018 - 10/2013
2	Myocardial Infarction 01/2016 - 03/2013
2	Fatigue 03/2015 - 12/2014
2	Autoimmune Diseases (Autoimmune Disease) 05/2003 - 01/2002
1	Necrosis 02/2021
1	Headache (Headaches) 11/2020
1	Osteoporosis 07/2019
1	Chronic Hepatitis C 07/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Fatty Liver 01/2019
1	Myalgia 01/2017
1	Anorexia 03/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2014
1	Exanthema (Rash) 12/2014
1	Dizziness (Lightheadedness) 12/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2014
1	Chronic Hepatitis B 12/2014
1	Muscular Diseases (Myopathy) 12/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2014
1	Hypertriglyceridemia 02/2014
1	Renal Insufficiency (Renal Failure) 01/2014
1	Opportunistic Infections (Opportunistic Infection) 01/2011
1	Hyperlipidemias (Hyperlipidemia) 09/2009

Drug/Important Bio-Agent (IBA)

11	Ritonavir (Norvir)FDA Link 04/2020 - 09/2009
8	Rosuvastatin Calcium (Crestor)FDA Link 02/2021 - 05/2012
8	Raltegravir Potassium FDA Link 01/2020 - 12/2014
7	Protease Inhibitors (Protease Inhibitor)IBA 11/2019 - 09/2009
6	Tenofovir (Viread)FDA Link 04/2024 - 09/2009
6	Biomarkers (Surrogate Marker)IBA 02/2021 - 05/2012
5	Integrase InhibitorsIBA 04/2024 - 12/2014
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2021 - 05/2012
4	LipidsIBA 04/2024 - 09/2009
4	dolutegravirIBA 04/2024 - 01/2019
4	Emtricitabine (Emtriva)FDA Link 01/2022 - 09/2009
4	Interleukin-6 (Interleukin 6)IBA 02/2021 - 05/2012
4	C-Reactive ProteinIBA 02/2021 - 05/2012
4	IntegrasesIBA 01/2021 - 10/2017
4	Darunavir (Prezista)FDA Link 04/2020 - 09/2015
4	Triglycerides (Triacylglycerol)IBA 11/2019 - 02/2016
3	lamivudine drug combination abacavir FDA Link 01/2022 - 09/2009
3	Maraviroc FDA Link 01/2019 - 10/2013
3	Atorvastatin (Lipitor)FDA Link 01/2018 - 05/2012
2	LDL CholesterolIBA 04/2024 - 07/2023
2	Insulin (Novolin)FDA Link 04/2024 - 01/2019
2	tenofovir alafenamideIBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 11/2020 - 07/2019
2	abacavir (Ziagen)FDA Link 11/2019 - 01/2016
2	NucleosidesIBA 01/2019 - 10/2017
2	CholesterolIBA 01/2017 - 01/2014
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2017 - 12/2014
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 01/2014
2	efavirenz (Sustiva)FDA Link 01/2016 - 09/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 05/2012
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	drug combination tenofovir alafenamide emtricitabine bictegravirIBA 04/2024
1	doravirineIBA 04/2024
1	imidazole mustard (BIC)IBA 04/2024
1	Lamivudine (Epivir)FDA Link 04/2024
1	bictegravirIBA 01/2022
1	CobicistatIBA 01/2020
1	elvitegravirIBA 01/2020
1	RacivirIBA 01/2020
1	FumaratesIBA 11/2019
1	Vitamin D FDA LinkGeneric 07/2019
1	LeptinIBA 01/2019
1	Nevirapine (Viramune)FDA Link 10/2017
1	HDL CholesterolIBA 01/2017
1	fibrin fragment D (D-dimer)IBA 01/2017
1	25-hydroxyvitamin DIBA 01/2017
1	Interleukin-12 (IL 12)IBA 01/2017
1	SteroidsIBA 01/2014
1	Dihydrotachysterol (AT 10)IBA 03/2013
1	Pravastatin (Pravachol)FDA LinkGeneric 05/2012
1	Lopinavir FDA Link 02/2011
1	ThymidineIBA 09/2009
1	Atazanavir Sulfate (Reyataz)FDA Link 09/2009

Therapy/Procedure

14	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 05/2003
13	Therapeutics 04/2020 - 01/2002
2	Polypharmacy 03/2015 - 12/2014
1	Radiotherapy 12/2014
1	Drug Therapy (Chemotherapy) 12/2014